Robert V. Considine, PhD

Administrative Director of the Lilly Diabetes Center of Excellence

Joined the IBRI in 2018

Robert Considine

Robert V. Considine, PhD, is a professor of medicine in the division of endocrinology at the Indiana University (IU) School of Medicine. Considine’s research is focused on understanding the contribution of obesity to the development of diabetes and its complications.

Early work focused on the function of the adipose tissue hormone leptin in humans. More recently, the Considine Lab has focused on the effects of bariatric surgery to alter gut hormone release and improve glucose homeostasis and insulin sensitivity.

In collaboration with David Kareken, PhD, at the IU School of Medicine, Considine also  is utilizing neuroimaging techniques to understand the reward system response to food cues in human subjects.

Considine is the Associate Director of the National Institutes of Health (NIH)-funded Center for Diabetes and Metabolic Diseases (CDMD) at the IU School of Medicine, and oversees the Analyte Laboratory, which provides quantitation of adipokines, cytokines, gut peptides and hormones from human and animal samples.

View Considine's published research here.

Areas of Expertise

  • Animal models
  • Biochemistry
  • Clinical trials
  • Drug discovery
  • Immunology
  • Internal medicine
  • Microscopy
  • Translational research

Education

  • Doctor of Philosophy (Physiology), Thomas Jefferson University, 1990
  • Bachelor of Science (Chemical Engineering), University of Delaware, 1985